Effectiveness of Four Different Treatment Modalities in the Treatment of Chronic Plantar Fasciitis During a 36-Month Follow-Up Period: A Randomized Controlled Trial

• Published in: The Journal of foot and ankle surgery Vol. 57; no. 5; pp. 913 - 918
• Main Authors: Uğurlar, Meriç, Sönmez, Mesut Mehmet, Uğurlar, Özge Yapıcı, Adıyeke, Levent, Yıldırım, Hakkı, Eren, Osman Tuğrul
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-09-2018
• Subjects: Adrenal Cortex Hormones - therapeutic use; Adult; Anesthetics, Local - administration & dosage; Bupivacaine - administration & dosage; Chronic Disease; corticosteroid; extracorporeal shock wave therapy; Extracorporeal Shockwave Therapy; Fasciitis, Plantar - complications; Fasciitis, Plantar - therapy; Female; Follow-Up Studies; Heel Spur - complications; Humans; injection; Injections; Male; Middle Aged; Pain Measurement; plantar fasciitis; Platelet-Rich Plasma; Prolotherapy; Prospective Studies; Treatment Outcome; Visual Analog Scale; Young Adult; 1; prolotherapy; plantar fasciitis; corticosteroid; extracorporeal shock wave therapy; injection; platelet-rich plasma
• ISSN: 1067-2516; 1542-2224
• DOI: 10.1053/j.jfas.2018.03.017

No consensus has been reached about the best treatment method of plantar fasciitis and the results of the treatment methods have been inconsistent. The objective of the present study was to compare the therapeutic effects of extracorporeal shock wave therapy, platelet-rich plasma injection, local corticosteroid injection, and prolotherapy for the treatment of chronic plantar fasciitis using a randomized, controlled, prospective study. We performed a randomized controlled prospective clinical study of 4 groups. The first group received extracorporeal shock wave therapy, the second group received prolotherapy, the third group received platelet-rich plasma injection, and the fourth group received a local corticosteroid injection. The study included 158 consecutive patients with a diagnosis of chronic plantar fasciitis with a symptomatic heel spur. The clinical outcomes were assessed using the visual analog scale and Revised Foot Function Index. At the end of the follow-up period, the mean visual analog scale scores for all 4 groups were similar to the mean visual analog scale scores before treatment. At the end of the follow-up period, no significant improvement was noted in the Revised Foot Function Index score in any of the groups. The corticosteroid injection was more effective in the first 3 months and extracorporeal shock wave therapy was an effective treatment method in the first 6 months in regard to pain. The corticosteroid injection lost its effectiveness during the follow-up period. The effect of prolotherapy and platelet-rich plasma was seen within 3 to 12 months; however, at the 36-month follow-up point, no differences were found among the 4 treatments.